SARCLISA ESCENA
Jul 20, 2026
Sanofi’s SARCLISA ESCENA Makes History as the First Wearable Cancer Treatment
Summary SARCLISA ESCENA is the first anticancer treatment approved for delivery via an on-body injector — approved in the US, EU, and UK. It's delivered via CirCLIQ, a hands-free wearable device built on Enable Injections' enFuse platform. Approval was supported by the Phase 3 IRAKLIA trial, showing effic...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
